Elsevier Celebrates the 200th Anniversary of Karolinska Institute with Freely Available Special Issues
Amsterdam, 3 June, 2010 - Elsevier, the leading publisher of scientific, technical and medical information products and services, announced today the publication of two freely available special issues to commemorate the 200th Anniversary of Karolinska Institutet (Stockholm, Sweden). The publications, publicly available until 1 August 2010, are:
Recent Progress in Molecular Sciences: Reviews from Karolinska Institutet at its 200-year Anniversary.
Biochemical and Biophysical Research Communications (BBRC)
Guest editors: Hans Jörnvall and Sten Orrenius
Special Issue Celebrating the 60-Year Anniversary of ECR and the 200-Year Anniversary of the Karolinska Institute
Experimental Cell Research (ECR)
Editor: Urban Lendahl
Karolinska Institute (KI) was founded in 1810 and, to mark the occasion, BBRC and ECR decided to simultaneously publish special anniversary issues that present mini-reviews, written by leading scientists from the Karolinska Institute, illustrating recent developments within areas of biomedical research at the molecular level. The fruits of their labor, two compelling collections of review articles, are now freely available online. These will give the scientific community a glance at the high quality research performed in this leading center.
Remarkably, five scientists at the Karolinska Institute have received the Nobel Prize in Physiology and Medicine. Those areas embody relevant research subjects at the institute, such as biochemistry, neurobiology and physiology. Other important research fields include immunology, cell and tumor biology, endocrinology, cardiology, blood coagulation, proteomics and molecular genetics, as well as methodological advances, such as mass spectrometry and cellular and molecular imaging; recent developments within all of these research fields are outlined in the special issue of BBRC. Also, many of the Karolinska Institute’s original discoveries of the past 50 years were published in this journal.
Similarly, this year is singular for Experimental Cell Research, as it celebrates its 60th anniversary. Several landmark papers have been published in ECR over the years, and a number of Nobel Laureates were members of its Editorial Board. The journal quickly established itself as a leading journal in cell and molecular biology—a position it still holds.
“We salute both the journal and the institute by publishing specials issues in ECR and BBRC, with contributions from leading scientists at KI. Elsevier is proud to be associated with such a centre of excellence,” said publishing director for Life Sciences, Carl Schwarz.
Free access to these unique collections is made available through ScienceDirect.
# # #
About Experimental Cell Research
Experimental Cell Research promotes the understanding of cell biology by publishing experimental studies on the general organization and activity of cells. The scope of the journal includes all aspects of cell biology, from the molecular level to the level of cell interaction and differentiation.
Experimental Cell Research publishes papers in the area of cell and molecular biology, and papers must provide novel and significant insights into important problems in these areas.
About Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. The development of the "Breakthroughs and Views" section brings the minireview format to the journal, and issues often contain collections of special interest manuscripts. is published weekly (52 issues/year).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com